European Medicines Agency - Regulatory - Regulation of medicines

4 - Quality management



    Description

Name

 

PRINTO - Pediatric Rheumatology International Trials Organisation

Documented adherence to GCP guideline Yes This is valid for studies with pharma industry while for academic studies funding are not sufficient for a proper local monitoring
Documented adherence to the ethical considerations for clinical trials in children Yes all studies are approved by the local ethics committees according to the law of the participating country
Documented adherence to ethical considerations Yes Not all ethics committees have a declared pediatric expertise
Availability of Standard Operating Procedures (SOP) Yes PRINTO obtained certification by ISO 9001 in February 2009, renewed in September 2012 for the period 2012-2015. SOP are available in-house and they mainly relate to the assessment of response to therapy in JIA on behalf of pharmaceutical industries
Capacity to monitor studies
(academic trials industry sponsored trials)
Yes For academic studies monitoring is done through standardises questionnaires (no local monitoring available for funding issues). For pharma sponsored studies GCP monitoring is done by the companies
Capacity to monitor performance of collaborating centres Yes Performance is evaluated by the rate of recruitment in collaborative studies
Quality control and quality assurance, raceability and data safety Yes Quality control for primary outcome assessment for pharma companies is done via fax/e-mail by receiving related data. For academic studies monitoring for efficacy and safety is done entirely by PRINTO centrally with electronic methods (no local monitoring)